| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/25/2005 | EP1165081B1 Process for preparing tolperison-containing pharmaceutical preparations for oral administration |
| 05/25/2005 | EP1165058B1 Azalide antibiotics for the topical treatment or prevention of ocular infections |
| 05/25/2005 | EP1162992B1 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
| 05/25/2005 | EP1161146B1 Deep penetrating antimicrobial compositions |
| 05/25/2005 | EP1056473B1 Targeted delivery of biologically active media |
| 05/25/2005 | EP1047701B1 Mitochondrially targeted antioxidants |
| 05/25/2005 | EP1044023B1 A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia |
| 05/25/2005 | EP1033132B1 Rapidly soluble drug composition comprising micronized as-3201 |
| 05/25/2005 | EP1027061B1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
| 05/25/2005 | EP0966304B1 Site-specific drug delivery |
| 05/25/2005 | EP0871702B1 Cytokine designated lerk-7 |
| 05/25/2005 | CN1620655A System and method for controlling user interface attribute by data |
| 05/25/2005 | CN1620496A Method for producing a water-alcohol solution and products based thereon |
| 05/25/2005 | CN1620469A Crystalline mixtures of partial methyl ethers of beta cyclodextrin and related compounds |
| 05/25/2005 | CN1620413A Method for stabilizing reduced coenzyme Q 10 and composition therefor |
| 05/25/2005 | CN1620333A Apparatus and process for preparing crystalline particles |
| 05/25/2005 | CN1620314A Gas micro-liposome compound |
| 05/25/2005 | CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 05/25/2005 | CN1620284A Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tool for producing it |
| 05/25/2005 | CN1620283A Dispersions for formulating slightly or poorly soluble active ingredients |
| 05/25/2005 | CN1620282A Pharmaceutical suspension for oral administration |
| 05/25/2005 | CN1620281A Formulation & dosage form for the controlled delivery of therapeutic agents |
| 05/25/2005 | CN1620257A Matrix-forming composition containing pectin |
| 05/25/2005 | CN1620255A Protein-containing foodstuff comprising a coss-linking enzyme and a hydrocolloid |
| 05/25/2005 | CN1620253A Seal oil based lipid emulsions and uses thereof |
| 05/25/2005 | CN1620251A Cultured and encapsulated pancreatic stem cells |
| 05/25/2005 | CN1618468A Series non-virus carrier, and medicinal composition contg. same |
| 05/25/2005 | CN1618467A Lignin base controlled releasing material |
| 05/25/2005 | CN1618466A Vaccine for treating hepatitis B, and its prepn. method |
| 05/25/2005 | CN1618465A 联合疫苗组合物 Combined vaccine composition |
| 05/25/2005 | CN1618322A Method for producing tablet, baked product or chewing gum |
| 05/25/2005 | CN1202863C Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 05/25/2005 | CN1202833C Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 05/25/2005 | CN1202829C Pharmaceutical formulations |
| 05/25/2005 | CN1202815C Delayed-action form of administration containing tramadol saccharinate |
| 05/25/2005 | CN1202814C Controlled releasing Qumaduo preparation having stably releasing mode and preparing method thereof |
| 05/25/2005 | CN1202812C Direct compression polymer tablet core |
| 05/25/2005 | CN1202798C Water in oil emulsified composition |
| 05/25/2005 | CN1202796C Method for making capsules by polymeric material film and capsules |
| 05/24/2005 | US6897349 Silver-containing compositions, devices and methods for making |
| 05/24/2005 | US6897305 Compound for use as tool in human disgnostics and therapeutics |
| 05/24/2005 | US6897239 New use of existing pharmaceutical misoprostol antiulcer agent, has a strong local vasodilation effect on applied tissue; a synergic action with combining alprostadil |
| 05/24/2005 | US6897218 Nitric oxide donors based on metallic centers |
| 05/24/2005 | US6897205 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 05/24/2005 | US6897203 Polysaccharidic esters of retinoic acid |
| 05/24/2005 | US6897200 Drug delivery a macromolecular complexes containing antitumor agent conjugated with a viral and non-viral RNA or vectors; stable, nonhydrolysis, gene therapy |
| 05/24/2005 | US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters |
| 05/24/2005 | US6897039 For treatment of cardiovascular diseases. |
| 05/24/2005 | US6897034 Antitumor agents; drug immobilized to oligopeptide; complexing; testing, calibration of complex to see if capable of being split enzyme; drug design |
| 05/24/2005 | US6896906 A spray dried powder prepared by aerosolization; superior chemical and physical stability over their solution counterparts; inhaleable powder |
| 05/24/2005 | US6896904 Multilayer crosslinking porous structure; prosthetic bones, drug delivery |
| 05/24/2005 | US6896901 Controlling or preventing cognitive dysfunction, hyperglycemia and some infective conditions of the skin in mammals by administering pharmaceutically acceptable effective amount of gugulipid |
| 05/24/2005 | US6896899 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 05/24/2005 | US6896897 For cosmetic and over-the-counter drug applications |
| 05/24/2005 | US6896895 Carotenoid esters, carotenoid-enriched feeds, and methods of pigmenting foods and foodstuffs |
| 05/24/2005 | US6896894 Proteins stabilized with polysaccharide gums |
| 05/24/2005 | US6896875 Mixable combination for generating a suspension of stable microbubbles for ultrasonic imaging |
| 05/24/2005 | US6896871 For therapy of soft tissues surrounding bone and bone-related diseases, such as bone cancer and osteoporosis |
| 05/24/2005 | US6896870 Diagnostic probes and therapeutics targeting uPA and uPAR |
| 05/24/2005 | US6896659 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
| 05/24/2005 | CA2432405C Water-free skin care formulations comprising micronized urea and method of manufacturing the same |
| 05/24/2005 | CA2315408C A double capsule for the administration of active principles in multiple therapies |
| 05/24/2005 | CA2268140C Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
| 05/24/2005 | CA2240161C Antifungal compositions with improved bioavailability |
| 05/24/2005 | CA2214889C Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and a process for the production thereof |
| 05/24/2005 | CA2144077C Hydrogel-type sustained-release preparation |
| 05/24/2005 | CA2109259C Prodrugs, their preparation and use as pharmaceuticals |
| 05/21/2005 | CA2486838A1 Organic amine salts of glutamic acid derivatives and their application |
| 05/19/2005 | WO2005045041A2 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | WO2005045040A2 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID /siNA) |
| 05/19/2005 | WO2005044985A2 Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections |
| 05/19/2005 | WO2005044965A1 Use of a solution comprising at least one nonionic surfactant |
| 05/19/2005 | WO2005044881A1 Carrier for nucleic acid molecule delivery |
| 05/19/2005 | WO2005044322A1 Methods of inhibiting the adherence of lenses to their packaging materials |
| 05/19/2005 | WO2005044309A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 05/19/2005 | WO2005044308A1 Phosphonate analogs of antimetabolites |
| 05/19/2005 | WO2005044297A1 Use of interferon-tau in medecine |
| 05/19/2005 | WO2005044287A1 Disinfecting composition and methods of making and using same |
| 05/19/2005 | WO2005044284A1 Compositions and uses therof |
| 05/19/2005 | WO2005044280A1 Biphosphonate pharmaceutical formulations (water emulsion of lipids/phospholipids) and use thereof |
| 05/19/2005 | WO2005044279A1 Purine nucleoside phosphonate conjugates |
| 05/19/2005 | WO2005044257A1 Discodermolide compositions |
| 05/19/2005 | WO2005044255A1 Stabilized pharmaceutical compositions |
| 05/19/2005 | WO2005044242A1 Preparations for topical application and methods of delivering an active agent to a substrate |
| 05/19/2005 | WO2005044237A1 Pharmaceutical composition having a cationic excipient |
| 05/19/2005 | WO2005044232A1 A controlled-release composition for topical application and a method of delivering an active agent to a substrate |
| 05/19/2005 | WO2005044227A1 Topical pharmaceutical compositions |
| 05/19/2005 | WO2005044224A2 Drug delivery system based on polymer nanoshells |
| 05/19/2005 | WO2005044223A1 Chewable tablet |
| 05/19/2005 | WO2005027978A3 Albumin-binding derivatives of therapeutic peptides |
| 05/19/2005 | WO2005025501A3 Co-administration of polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 05/19/2005 | WO2005015158A9 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 05/19/2005 | WO2005013934A3 Taste-masked composition of cationic exchange resin |
| 05/19/2005 | WO2004100997A3 Spacer moiety for poly(ethylene glycol) -modified peptides |
| 05/19/2005 | WO2004100979A3 Liquid stabilized protein formulations in coated pharmaceutical containers |
| 05/19/2005 | WO2004091529B1 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |
| 05/19/2005 | WO2004069201A3 Compounds useful in coating stents to prevent and treat stenosis and restenosis |
| 05/19/2005 | WO2004064719A3 Synergistic compositions and methods for potentiating anti-oxidative activity |
| 05/19/2005 | WO2003105767A8 Antifungal parenteral products |
| 05/19/2005 | WO2003009815A3 Compositions and methods for modulating blood-brain barrier transport |